EP Patent

EP2575818A2 — The use of inhibitors of bruton's tyrosine kinase (btk)

Assigned to Pharmacyclics LLC · Expires 2013-04-10 · 13y expired

What this patent protects

Patent listed against Imbruvica.

Drugs covered by this patent

Patent Metadata

Patent number
EP2575818A2
Jurisdiction
EP
Classification
—
Expires
2013-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacyclics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.